EX-23.2 3 cgem-ex23_2.htm EX-23.2 EX-23.2

Exhibit 23.2

 

 

 

img108548027_0.jpg 

 

KPMG LLP

Two Financial Center

60 South Street

Boston, MA 02111

Consent of Independent Registered Public Accounting Firm

We consent to the use of our report dated March 14, 2024, with respect to the consolidated financial statements of Cullinan Oncology, Inc., incorporated herein by reference.

 

/s/ KPMG LLP

Boston, Massachusetts

March 14, 2024